Literature DB >> 32702629

Molecular margins in head and neck cancer: Current techniques and future directions.

Katelyn O Stepan1, Michael M Li2, Stephen Y Kang2, Sidharth V Puram3.   

Abstract

Complete tumor extirpation with clear surgical margins remains a central tenet of oncologic head and neck surgery. Rates of locoregional recurrence and survival are both significantly worse when clear margins are unable to be obtained. Current clinical practice relies on the use of frozen sections intra-operatively, followed by traditional histopathologic analysis post-operatively to assess the surgical margin. However, with improved understanding of tumor biology and advances in technology, new techniques have emerged to analyze margins at a molecular level. Such molecular margin analysis interrogates tissue for genetic, epigenetic, or proteomic changes that may belie tumor presence or aggressive features not captured by standard histopathologic techniques. Intra-operatively, this information may be used to guide resection, while post-operatively, it may help to stratify patients for adjuvant treatment. In this review, we summarize the current state of molecular margin analysis and describe directions for future research.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Fluorescence; Head and neck cancer; Margin analysis; Molecular margin; Next-generation sequencing; Spectroscopy

Year:  2020        PMID: 32702629      PMCID: PMC8131031          DOI: 10.1016/j.oraloncology.2020.104893

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  104 in total

1.  p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins.

Authors:  Xiaohong Huang; Stelios Pateromichelakis; Allison Hills; Martyn Sherriff; Andrew Lyons; John Langdon; Edward Odell; Peter Morgan; John Harrison; Max Partridge
Journal:  Clin Cancer Res       Date:  2007-10-15       Impact factor: 12.531

2.  Prediction of recurrence by microsatellite analysis in head and neck cancer.

Authors:  I Sardi; A Franchi; G Ferriero; A Frittelli; L Bruschini; E Montali; O Gallo
Journal:  Genes Chromosomes Cancer       Date:  2000-11       Impact factor: 5.006

3.  Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment.

Authors:  L Mao; J S Lee; Y H Fan; J Y Ro; J G Batsakis; S Lippman; W Hittelman; W K Hong
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

4.  Highly Accurate Detection of Cancer In Situ with Intraoperative, Label-Free, Multimodal Optical Spectroscopy.

Authors:  Michael Jermyn; Jeanne Mercier; Kelly Aubertin; Joannie Desroches; Kirk Urmey; Jason Karamchandiani; Eric Marple; Marie-Christine Guiot; Frederic Leblond; Kevin Petrecca
Journal:  Cancer Res       Date:  2017-06-28       Impact factor: 12.701

5.  KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.

Authors:  Semra Demokan; Xiaofei Chang; Alice Chuang; Wojciech K Mydlarz; Jatinder Kaur; Peng Huang; Zubair Khan; Tanbir Khan; Kimberly L Ostrow; Mariana Brait; Mohammad O Hoque; Nanette J Liegeois; David Sidransky; Wayne Koch; Joseph A Califano
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

6.  Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas.

Authors:  Tiziana Martone; Anna Gillio-Tos; Laura De Marco; Valentina Fiano; Milena Maule; Andrea Cavalot; Massimiliano Garzaro; Franco Merletti; Giorgio Cortesina
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

7.  Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue.

Authors:  Parul Sinha; S Bahadur; Alok Thakar; Ajay Matta; Muzafar Macha; Ranju Ralhan; S Datta Gupta
Journal:  Head Neck       Date:  2009-11       Impact factor: 3.147

8.  Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period.

Authors:  A Eckardt; E L Barth; H Kokemueller; G Wegener
Journal:  Oral Oncol       Date:  2004-04       Impact factor: 5.337

9.  Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.

Authors:  Edmund A Mroz; Krupal B Patel; James W Rocco
Journal:  Cancer       Date:  2020-02-21       Impact factor: 6.860

10.  In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas.

Authors:  Esther de Boer; Jason M Warram; Matthew D Tucker; Yolanda E Hartman; Lindsay S Moore; Johannes S de Jong; Thomas K Chung; Melissa L Korb; Kurt R Zinn; Gooitzen M van Dam; Eben L Rosenthal; Margaret S Brandwein-Gensler
Journal:  Sci Rep       Date:  2015-06-29       Impact factor: 4.379

View more
  2 in total

Review 1.  Partial EMT in head and neck cancer biology: a spectrum instead of a switch.

Authors:  Ananya Pal; Thomas F Barrett; Rachel Paolini; Anuraag Parikh; Sidharth V Puram
Journal:  Oncogene       Date:  2021-07-08       Impact factor: 8.756

2.  Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma.

Authors:  Anuraag Parikh; JuneHo Shin; William Faquin; Derrick T Lin; Itay Tirosh; John B Sunwoo; Sidharth V Puram
Journal:  J Immunother Cancer       Date:  2020-09       Impact factor: 13.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.